Publicly Traded Regenerative Medicine CompaniesU.S. Exchanges
List of Publicly Traded Companies Focusing on Regenerative Medicine Listed on Major U.S. Exchanges
The companies on this list are regenerative medicine companies or companies engaged in providing regenerative devices, equipment, products and/or services. These companies’ products and services are used by other companies within the health care and life science markets.
Additional publicly traded biotech and pharmaceutical companies and categories can be accessed through the links below:
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Select the company’s link to access charts, news links and company website and social media information.
Regenerative Medicine Technology: Mid-Cap Stocks
Integra LifeSciences Holdings Corporation (IART) (Regenerative technology implants; medical devices: orthopedic, spine, general surgery)
Regenerative Medicine Technology: Small-Cap Stocks
BioTime, Inc. (BTX) (Biotechnology company: regenerative medicine to patients with serious diseases and degenerative conditions)
Mesoblast Ltd. (MESO) (IPO in November 2015, Australia: regenerative medicine company; areas of focus include inflammation, cardiovascular disease and back pain)
MiMedx Group, Inc. (MDXG) (Regenerative biomaterial products and bioimplants; wound care)
Regenerative Medicine Technology: Micro-Cap Stocks
Asterias Biotherapeutics, Inc. (AST) (Biotechnology company: regenerative medicine; therapeutics developed from platforms based on pluripotent stem cells and dendritic cell cancer immunotherapy)
Athersys, Inc. (ATHX) (Biopharmaceutical company: most advanced programs in area of regenerative medicine; stem cell products)
Osiris Therapeutics, Inc. (OSIR) (Regenerative products for wound care, sports medicine and orthopaedics)
Regenerative Medicine Technology: Nano-Cap Stocks
Biostage, Inc. (BSTG) (Bioengineered organ implants)
Cesca Therapeutics Inc. (KOOL) (Cell-based therapeutics for use in regenerative medicine)
Cytori Therapeutics Inc. (CYTX) (Clinical stage company: cell therapies to treat cardiovascular disease and repair soft tissue defects)
Histogenics Corporation (HSGX) (Regenerative medicine company: products used to treat musculoskeletal-related conditions)
Xtant Medical Holdings, Inc. (XTNT) (Medical devices and regenerative medicine products for the orthopedic and neurosurgery markets)